Last updated on September 2018

Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria


Brief description of study

The aim of this non-interventional study is to assess oral vinorelbine dose schedules (initial dose, dose increase/maintenance/reduction) applied during the initial 8 weeks of treatment under routine conditions in Germany together with the underlying reasons for the respective chosen schedules.

Clinical Study Identifier: NCT02619929

Contact Investigators or Research Sites near you

Start Over

Winicker Norimed

Kiel, Germany